British Journal of Clinical Pharmacology · 1986 · 196 citations · 16 references
PharmacyPharmacokineticsPharmacologyBioavailabilityDrug ClearanceRenal PharmacokineticsDrug DispositionDrug Half-lifeRenal Drug ClearanceRenal Drug DistributionDrug Disposition PharmacokineticsPharmacokinetic ParametersPlasma Clearance EstimationRenal Blood ClearanceRenal Plasma ClearanceUnchanged Drug ExcretionUrinary Excretion KineticsUrinary Pharmacokinetics
The pharmacokinetics of salbutamol and its sulphate conjugate metabolite were investigated after intravenous and steady-state oral administration of salbutamol to 10 healthy volunteers. With intravenous administration, total plasma clearance was 480 +/- 123 ml min-1, elimination half-life was 3.86 +/- 0.83 h and apparent volume of distribution was 156 +/- 381. Urinary excretion of unchanged drug and sulphate conjugate were 64.2 +/- 7.1% and 12.0 +/- 3.1% of the dose, respectively. With oral administration, systemic availability was 0.50 +/- 0.04, and urinary excretion of unchanged drug and sulphate conjugate were 31.8 +/- 1.9% and 48.2 +/- 7.3% of the dose, respectively. The drug eliminated on the first-pass could be accounted for entirely as sulphate conjugate formed, presumably, in the intestinal wall. Renal clearance of salbutamol was 291 +/- 70 ml min-1 after intravenous and 272 +/- 38 ml min-1 after oral administration, while the renal clearance of the sulphate conjugate was 98.5 +/- 23.5 ml min-1 after oral administration. Heart rate increased with increasing plasma salbutamol concentration, although a lag was evident. The effect on heart rate was lower after 24 h continuous oral salbutamol administration.
16
The clinical pharmacology of oral and inhaled salbutamol
Stuart Walker, M E Evans, Andrea Richards et al. · Clinical Pharmacology & Therapeutics · 1972 · 143 citations
The Metabolism of Salbutamol in Man
M E Evans, Stuart Walker, R T Brittain et al. · Xenobiotica · 1973 · 99 citations